EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Treatment of acute bleeding episodes with rFVIIa



Treatment of acute bleeding episodes with rFVIIa



Vox Sanguinis 77 Suppl 1: 42-46




(PDF same-day service: $19.90)

Accession: 035980748

Download citation: RISBibTeXText

PMID: 10529687

DOI: 56715



Related references

Recombinant activated clotting factor VII (rFVIIa) in the treatment of surgical and spontaneous bleeding episodes in hemophilic patients. Vascular Health and Risk Management 2(4): 433-440, 2007

Clinical use of recombinant human activated factor VII (rFVIIa) in the prevention and treatment of bleeding episodes in patients with Glanzmann's thrombasthenia. Vascular Health and Risk Management 3(5): 655-664, 2007

A systematic review of the cost-effectiveness of rFVIIa and APCC in the treatment of minor/moderate bleeding episodes for haemophilia patients with inhibitors. Haemophilia 15(2): 405-419, 2009

Economical comparison of APCC vs. rFVIIa for mild-to-moderate bleeding episodes in haemophilia patients with inhibitors. Haemophilia 17(5): E969-E974, 2011

Massive pulmonary embolism after treatment with rFVIIa in a thrombocytopenic patient with acute myelogenous leukemia and intractable bleeding. European Journal of Haematology 78(2): 173-174, 2007

Independent adjudicator assessments of platelet refractoriness and rFVIIa efficacy in bleeding episodes and surgeries from the multinational Glanzmann's thrombasthenia registry. American Journal of Hematology 92(7): 646-652, 2017

rFVIIa and a new enhanced rFVIIa-analogue, NN1731, reduce bleeding in clopidogrel-treated and in thrombocytopenic rats. Journal of Thrombosis and Haemostasis 7(4): 651-657, 2009

Application of rFVIIa for controlling acute bleeding in the obstetric and gynecologic practice. Akusherstvo i Ginekologiia 47 Suppl 3: 40-42, 2008

The role of activated recombinant factor VII (rFVIIa) in acute severe bleeding. Clinical Intensive Care 15(4): 115-117, 2004

Etiologic factors and treatment of acute bleeding episodes in the older patient. Journal of the American Geriatrics Society 15(11): 1010-1011, 1967

Treatment of bleeding with rFVIIa in four diverse cases. Blood 98(11 Part 1): 263a, November 16, 2001

Treatment of postoperative bleeding after fondaparinux with rFVIIa and tranexamic acid. Netherlands Journal of Medicine 63(5): 184-186, 2005

Treatment with rFVIIa for prophylaxis of bleeding and reduction in inhibitor titer in hemophiliacs with inhibitors. Blood 98(11 Part 2): 86b, November 16, 2001

Retrospective study of rFVIIa, 4-factor PCC, and a rFVIIa and 3-factor PCC combination in improving bleeding outcomes in the warfarin and non-warfarin patient. American Journal of Hematology 91(7): 705-708, 2016

Recombinant factor VIIa (rFVIIa) - a universal hemostatic agent? Use of rFVIIa in controlling bleeding in patients with platelet disorders FT Rekombinowany aktywny czynnik VII (rVIIa) - uniwersalny lek przeciwkrwotoczny? Zastosowanie rVIIa w leczeniu krwawien u chorych ze skazami plytkowymi. 2007